Your browser doesn't support javascript.
loading
Nano-carriers of COVID-19 vaccines: the main pillars of efficacy.
Constantin, Carolina; Pisani, Anissa; Bardi, Giuseppe; Neagu, Monica.
Afiliação
  • Constantin C; "Victor Babes" National Institute of Pathology, 99-101 Spl Independentei, Bucharest, 050096, Romania.
  • Pisani A; Colentina Clinical Hospital, 19-21, Sos. Stefan cel Mare, Bucharest, Romania.
  • Bardi G; Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia, Via Morego 30, Genova, 16163, Italy.
  • Neagu M; Department of Chemistry & Industrial Chemistry, University of Genova, Via Dodecaneso 31, Genova, 16146, Italy.
Nanomedicine (Lond) ; 16(26): 2377-2387, 2021 11.
Article em En | MEDLINE | ID: mdl-34632802
As the current COVID-19 pandemic illustrates, vaccination is the most powerful method of disease prevention and public confidence in vaccines depends on their safety and efficacy. The information gathered in the current pandemic is growing at an accelerated pace. Both the key vital protein DNA/RNA messengers and the delivery carriers are the elements of a puzzle including their interactions with the immune system to suppress SARS-CoV-2 infection. A new nano-era is beginning in the vaccine development field and an array of side applications for diagnostic and antiviral tools will likely emerge. This review focuses on the evolution of vaccine carriers up to COVID-19-aimed nanoparticles and the immune-related adverse effects imposed by these nanocarriers.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Romênia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Romênia